Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 1 Study of S-3304 in Patients With Solid Tumors

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2003 by Shionogi.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Shionogi
ClinicalTrials.gov Identifier:
NCT00033215
First received: April 9, 2002
Last updated: June 23, 2005
Last verified: November 2003

April 9, 2002
June 23, 2005
November 2001
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00033215 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors

To determine the maximum tolerated dose and safety profile of S-3304 in patients with biopsy accessible cancer who have failed previous therapy or to whom no standard therapies are available. To determine the pharmacokinetic profile of S-3304 in this patient population

Not Provided
Interventional
Phase 1
Allocation: Non-Randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Solid Tumors
Drug: S-3304
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
28
October 2003
Not Provided

Inclusion criteria:

  • Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)
  • Must be able to tolerate oral medication Exclusion criteria
  • Patients with other serious illnesses
  • Patients who are receiving treatments
Both
18 Years to 85 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00033215
0110P1416
Not Provided
Not Provided
Shionogi
Not Provided
Not Provided
Shionogi
November 2003

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP